Hospital for Joint Diseases Hosts Annual Rose Dabbs Community Health Fair on Sunday, June 3rd, in Conjunction with the Third Avenue Spring Fair)
Come join us on Sunday, June 3rd from 12pm until 4pm for the annual Rose Dabbs Health Fair! This year, the Fair is being held in conjunction with the Third Avenue Spring Fair. HJD will have a space in the fair, on the corner of Third Avenue and 17th Street, where we’ll be offering free blood pressure screenings to registered attendants.
Other events featured at the Rose Dabbs Health Fair will include children’s activities, health education and information, and much more!
The event is sponsored by the NYU Langone Hospital for Joint Diseases Auxiliary, in collaboration with the Patient Centered Care Department.
Patrick Meere MD, Answers Hip Replacement Questions in the New York Times
Patrick Meere, MD, of the Department of Orthopaedic Surgery’s Adult Reconstructive Division, is featured in the New York Times Consults Blog answering reader questions about minimally invasive techniques for hip replacement that reduce complications and speed recovery.
HJD and New York Rangers Team Up
The New York Rangers—celebrating their 85th season in the National Hockey League—have officially become part of the NYU Langone community. Beginning on Friday, October 15, The Hospital for Joint Diseases is the designated official hospital of the Rangers for the next three years.
Many Rangers are already familiar with the HJD through an existing relationship with Andrew Feldman, MD, clinical assistant professor of orthopaedics and the new team physician and orthopaedic surgeon. The Department is proud of how this new partnership will make Rangers fans aware the wide range of sports medicine services available at HJD.
2010 Hospital for Joint Diseases' Founders Gala Raises over $1.7 Million
Over 600 Guests Attend Event to Honor James P. Riley Jr., Retired Managing Director and Partner at Goldman Sachs
November 10, 2010
NYU Langone Medical Center’s Hospital for Joint Diseases (HJD) raised over $1.7 million in unrestricted funds at its annual gala held last evening. The event took place at The American Museum of Natural History in Manhattan and honored James P. Riley Jr., retired managing director and partner at Goldman Sachs, for his longtime philanthropic support for HJD. The event was chaired by Gary D. Cohn, president and COO of The Goldman Sachs Group, Inc.
This year's gala celebrated HJD's accomplishments as one of the country's finest specialty hospitals in orthopaedics, rheumatology, neurology and rehabilitation, and its dedication to the prevention and treatment of neuromusculoskeletal disease. Through its physicians' and researchers' discoveries in medicine and surgical innovation, HJD has earned international recognition in research, medical education and patient care, improving the lives of countless people throughout the world. This year's event marked the 105th anniversary celebration of HJD.
Those in attendance included: Ken Langone, chairman of the Board of Trustees, NYU Langone Medical Center, and his wife, Elaine, Armen Avanessians, Chris Carrera, Susan Chapro, Mindy and Mark Dehnert, Michael Gardner, Alan Harris, Felix Kaufman, PhD, Stanley Katzman, Merrill M. Kraines, Linda and Timothy O'Neill, William A. Perlmuth, Douglas A. Phillips, MD, PhD, Alan S. Samuels, Beryl Snyder, Anthony G. Viscogliosi, Lisa and Richard Witten.
In addressing the crowd of over 600 guests, Robert I. Grossman, MD, dean and CEO of the Medical Center said, "Musculoskeletal disease is one of the key strategic areas of our Medical Center, and we have in place exciting plans to take HJD's pioneering work in orthopaedics and rheumatology to a whole new level, as we look toward the creation of the Musculoskeletal Institute, due to open in two years' time. The support we have received has catalyzed amazing strides in musculoskeletal health and the field of orthopaedics and I thank you for all the ways you make it possible for their talent and dedication to shine."
A nored included: Prisca Bernard-Joseph, RN, David Feldman, MD; Fritz Francois, MD, MS, Mary Ann Hopkins, MD, FACS, Kenneth J. Mroczek, MD, Patricia Poitevien, MD, and Lucia Daiana Voiculescu, MD.
Photos By Jay Brady Photography, Inc.
David Dibner, Dr. Andrew D. Rosenberg, James P. Riley, Jr., Gary D. Cohn
Photos By Jay Brady Photography, Inc.
Dr. Joseph Zuckerman (top left), Dr. Steven Abramson (top center), Dr. Andrew Rosenberg (top right) and HEART team members.
212-404-3500 | email@example.com
NYU Hospital for Joint Diseases Launches Robotic Arm Assisted Surgery To Treat Osteoarthritis of the Knee
Minimally invasive procedure may reduce post-surgical pain, facilitate enhanced recovery and return to normal activities
NEW YORK, NY, November 14, 2008 – The Department of Orthopaedic Surgery at NYU Hospital for Joint Diseases (NYUHJD) is now offering patients a new minimally invasive surgical procedure, MAKOplasty®, that incorporates a robotic arm system to perform partial knee replacements.
This robotic knee replacement surgery may be ideal for patients who have been diagnosed with early or mid-stage osteoarthritis (OA) in the inner portion of their knee, but have an otherwise healthy joint. OA is a type of arthritis that is caused by the breakdown and eventual loss of the cartilage in one or more joints. According to the American Geriatrics Society, about 50 percent of all persons age 65 and older are affected by OA.
“There is a large part of our population living with osteoarthritis in just one part of the knee who could be likely candidates for this procedure,” said Joseph Bosco, M.D., Vice Chair of Clinical Affairs of NYUHJD's Department of Orthopaedic Surgery. “In many cases, recovery is quicker and a return to normal lifestyle is easier with a partial knee replacement rather than a total knee replacement. We are very pleased to be able to offer this new treatment option to our patients,” he added.
The surgical procedure uses a guidance system that provides surgeons with a novel method of pre-surgical planning via 3-D digital visualization. Using CT (computed tomography) scans of the patient’s knee, the guidance system maps out the patient’s knee and highlights only the area to be resurfaced, thereby sparing healthy bone and tissue. During the procedure, the robotic arm offers the surgeon – who is in control of the device at all times – visual, tactile and acoustic feedback to ensure that the implants are optimally placed and only the diseased portions of the joint is removed.
About NYU Hospital for Joint Diseases
Founded in 1905, NYU Hospital for Joint Diseases is one of the world’s premier academic musculoskeletal medical institutions and a recognized leader in patient care, physician education, and research. The 190-bed facility, part of the NYU Langone Medical Center, specializes in orthopaedics, rheumatology, rehabilitation medicine, and neurology. Additional information is available at www.nyuhjd.org.
NYU Langone Medical Center Designates New Center of Excellence in Musculoskeletal Disease
NYU Langone Medical Center has established its first six new Centers of Excellence, including one on Musculoskeletal Disease, to bring together outstanding basic scientists and clinical researchers from the NYU Langone community to address some of today’s most pressing health challenges.
The goal is to foster a highly collaborative, multidisciplinary investigation that inspires new ideas and discoveries in areas long recognized as institutional strengths, and where possible, to translate scientific advances more swiftly into new ways of treating patients and diagnosing and preventing disease. The six centers will collectively receive $15 million in funding from the Medical Center over the next three years.
Co-Directors of the Center of Excellence on Musculoskeletal Disease are Steven Abramson, M.D., Professor of Medicine and Pathology, Director, Division of Rheumatology; and Joseph Zuckerman, M.D., Walter A.L. Thompson Professor and Chairman of the NYUHJD Department of Orthopaedic Surgery.
This Center will build on the expertise of the NYU School of Medicine and NYU Hospital for Joint Diseases to focus on arthritis, autoimmunity, and the repair/regeneration of musculoskeletal tissues. Collaborative studies will examine the basic biology of joint tissues and their functional decline with aging, develop methods to promote the regeneration of these tissues, and apply bioengineering to design more effective implants to replace defective or injured bone and cartilage.
The Center has five key areas of concentration: the Biology of the Joint, which will focus on molecular mechanisms of osteoarthritis, joint regeneration, and tissue repair; Diagnostics, Biomarkers and Predictive Medicine, which will develop tissue biorepositories to focus on genomics, pharmacogenetics and toxico-genetics; Clinical Research, with a focus on clinical trials and health outcomes; Lupus and Autoimmune Disease including the study of Rheumatoid Arthritis, Psoriatic Arthritis and Vasculitis; and Clinical Bioengineering.
A Center of Excellence on Multiple Sclerosis has also been designated with Co-Directors Joseph Herbert, M.D., Associate Professor, Department of Neurology (Neurorehabilitation/MS), and NYU Hospital for Joint Diseases; and James Salzer, M.D., Ph.D., Professor of Cell Biology and Neurology.
The Center’s mission is to develop a model system of multidisciplinary, comprehensive clinical and rehabilitative care and to provide patients with access to promising new treatments being tested in major multicenter drug trials or therapeutic strategies developed by our neuroscientists.
This Center will pursue causes of and cures for MS by integrating the efforts of nationally recognized experts in neuroimmunology and neurobiology, MS clinical care and research, and neuroimaging. The center’s neuroimaging colleagues will interface with basic scientists and clinicians in order to enhance the ability to detect the earliest MS lesions in the brain, to explore the pathogenesis of MS and to monitor new therapies that may inhibit progress of the disease.
These two centers and four others were chosen from over 75 letters of intent, and the Science Strategy Committee reviewed 18 full proposals. The Committee was guided by several key criteria which included leadership, outstanding national and international reputations, significant potential impact on society, evidence of existing interdisciplinary collaboration, substantial ongoing extramural funding with serious growth potential, and benefit to the institution as a whole.
The four other Centers of Excellence address addiction, brain aging and dementia, cancers of the skin, and urologic diseases.
Two NYUHJD Orthopaedic Surgeons Host Sirius Radio Show
Orthopaedic topics ranging from sports injuries to new joint replacement technologies will be addressed during a new program on Doctor Radio, a joint venture of Sirius Radio and NYU Langone Medical Center. Dr. Nader Paksima of the Hand Division and Dr. Ramesh Gidumal of the Sports Medicine Division will host their orthopaedics program on Mondays, from 6 p.m. to 8 p.m., on Sirius Channel 114.
Doctor Radio, available 24/7, features world-class physicians and surgeons from NYU Langone Medical Center who provide real medical information in a down-to-earth style. Listeners have the opportunity to call in (1-877-NYU-DOCS) and direct their medical questions to a broad range of specialists.
To read more about the orthopaedic program hosted by physicians at NYU Hospital for Joint Diseases, visit this link: http://www.sirius.com/doctorradio
Ground-breaking Surgical Table Facilitates Minimally Invasive Hip Replacement Surgery at NYU Hospital for Joint Diseases
New York, NY. August 7, 2008 – Surgeons at NYU Hospital for Joint Diseases (NYUHJD) have successfully performed a minimally invasive anterior total hip replacement using the innovative hana™ Hip and Knee Arthoplasty Table, a first for a New York academic medical center.
An anterior total hip replacement, as performed with the aid of the hana Hip and Knee Arthoplasty Table, is a cutting-edge procedure in contrast to the usual approach in total hip replacement surgery since it is performed through a natural interval among the muscle groups surrounding the hip. This interval allows replacement of the hip without the cutting of muscles and tendons which is required in all other approaches to the hip joint.
The complex operation is facilitated by the hana Table because it serves as an actual instrument during the operation. With its unique capability to position the leg, the hana Table enables the surgeon to replace the hip through a single incision, anterior approach, without detachment of muscle or tendon from the pelvis or femur.
Roy I. Davidovitch, M.D., an assistant professor in the Department of Orthopaedic Surgery at NYU School of Medicine, was the first surgeon to use the hana Table at NYUHJD. He heads the New York Hip Center, which provides patients with new, innovative treatments for different hip conditions. He trained with Dr. Joel Matta, the innovator of the Anterior Total Hip Replacement, of Santa Monica, in anterior approach hip replacement surgery.
“The hana Hip and Knee Arthoplasty Table provides a remarkable resource to facilitate anterior approach hip replacement procedures and is a breakthrough in the field of hip replacement surgery,” said Dr. Davidovitch. “The hana table has been a worthy addition to our resources on par with our robotic and computer navigation approach to joint replacement surgery."
"The anterior approach for hip replacement surgery results in less pain and an accelerated recovery. Most notably, patients are not asked to observe any special precautions after surgery and are encouraged to resume routine, low impact, activities,” adds Justin LaMont, M.D, Chief of the Orthopaedic Division at Tisch Hospital of NYU Langone Medical Center, who is also performing anterior hip replacements.
Merits of the anterior approach total hip replacement include: less muscle and tendon trauma for the patient; a reduced hospital stay; an accelerated recovery -- two to eight weeks as opposed to two to four months; a smaller incision -- four to five inches as opposed to 10 to 12 inches; the lack of post surgical precautions; and a reduction in pain. Additional benefits are low risk of hip dislocation, the reduction in blood loss, and a more rapid return to activities of daily living such as driving.
About NYU Hospital for Joint Diseases
One of the world’s premier academic musculoskeletal medical institutions for more than 100 years, NYU Hospital for Joint Diseases (NYUHJD) is a leader in patient care, physician education and research. NYU Hospital for Joint Diseases, a part of the NYU Langone Medical Center, boasts one of the largest volumes of Hip, Knee and Shoulder Arthroplasty procedures in the country with over 3,000 performed annually. Additional information is available at www.nyuhjd.org.
MizuhoOSI was founded in 1978 as Orthopedics Systems, Inc., and is now a subsidiary of the Mizuho Ikakogyo Co., Ltd., in Tokyo, Japan, who acquired OSI in 2002. Mizuho Ikakogyo is the leading general surgical table manufacturer in Japan and Asia. Mizuho was founded in 1922. MizuhoOSI is the leading orthopedic and spinal surgical table manufacturer worldwide. MizuhoOSI products are sold in the U.S. through direct sales representatives and worldwide through authorized international distributors. More information is available at www.mizuhosi.com and www.newhipnews.com.
NYUHJD Ranks Among the Elite In U.S. News and World Report’s Annual Survey
The Department of Orthopaedic Surgery at NYU Hospital for Joint Diseases moved up two notches in the 2008 “America’s Best Hospitals” edition of U.S. News and World Report to number eight, as compared with number ten last year. Meanwhile, the Division of Rheumatology held steady at number 11 and the Rusk Institute remained in the ‘Top Ten’ with a ranking in the eighth position. Only 170 hospitals in the country, out of 5,453 considered, scored high enough to appear in any of the 16 specialty rankings.
NYU Medical Center Changes Name to Honor Chairman of Board & Wife
New York, April 16, 2008— NYU Medical Center today announced it will be renamed the NYU Elaine A. and Kenneth G. Langone Medical Center, in honor of the chairman of its board of trustees and his wife, whose unrestricted $200 million gift is the largest in the Medical Center’s history.
The announcement was made by Robert I. Grossman, M.D., dean and CEO of the Medical Center, who said the renaming was in tribute to the Langones’ tireless efforts on behalf of the Medical Center, their generosity as champions of its mission, and their commitment to its future under its new leadership. The Langones’ contribution has already inspired additional gifts to the Medical Center, totaling $50 million.
A leading philanthropist and a major figure in business and finance, Kenneth Langone is best known as co-founder of the world’s largest home improvement retailer, Home Depot, a director of the New York Stock Exchange, and founder of the brokerage and investment banking firm Invemed. He has been a trustee of New York University since 1997 and chairman of the Medical Center’s Board of Trustees since 1999.
"What makes the Langone gift so remarkable is not just the amount, but the spirit in which it is given," said Dr. Grossman, who became dean and CEO in July 2007, after serving as chairman of the Department of Radiology at NYU for the prior six years. "Rather than being tied to a particular program, this distinctive contribution is being given in a very open-ended way to enable us to realize our dreams of innovation and excellence. The Langones’ generosity is both a powerful endorsement and a catalyst for our efforts to ensure that our Medical Center takes its rightful place as one of the very top institutions of its kind in the world."
"Elaine and I are designating the new NYU Langone Medical Center as our legacy to the city of New York because we believe in the quality and humanity of this Medical Center, one truly dedicated to relieving pain and suffering and giving people hope,"Mr. Langone said. "This institution has a fantastic track record for the quality of its care and for having some of the greatest doctors in the world. I have met absolutely remarkable people at all levels. But today there is a disconnect between much of the physical plant and the caliber of the work it houses. That’s why Elaine and I are choosing to make an unrestricted gift of this scale to help launch the vigorous aspirations of our inspired new leadership team.”
An Historic Act of Philanthropy
“The Langones are people of legendary generosity, enthusiasm, and loyalty,” said Martin Lipton, chairman of the New York University Board of Trustees. “This gift is not only an historic act of philanthropy from devoted members of the NYU family; it is a demonstration of their belief in an idea: that we can make one of New York’s foremost health care institutions even greater,” said Mr. Lipton. “We have been enormously privileged by the Langones’ involvement with NYU for so many years, and it is only fitting to rename the Medical Center in their honor. On behalf of the entire NYU community, I wish to express our gratitude for their abiding faith in our University and our Medical Center.”
“Ken Langone is justly renowned in business for a particular set of skills: the acumen to recognize those enterprises that are bound for success, and the courage to back them,” said NYU President John Sexton. “And that is just the point here: the decision by Ken and Elaine to support NYU, and in particular the Medical Center, in such an extraordinarily generous fashion is a peerless validation of all that we are striving to do to ensure the University’s place among the top institutions in the world in medicine and higher education,” said Mr. Sexton. “This gift is a major step forward for NYU; for New York City, which depends so much on the efforts of our Medical Center; and for the field of medicine, where NYU’s leadership matters so greatly. We are grateful to the Langones for their generosity, for their wisdom and guidance, and for their deep engagement with the NYU community.”
Gift to Support Multi-Year Transformation
The Langone gift will support the Medical Center’s plans for a major campus transformation, as envisioned by Dr. Grossman and his leadership team. This will include a series of initiatives to expand NYU’s clinical, educational, and biomedical sciences presence on Manhattan’s East Side. The centerpiece of the multi-year transformation will be a new hospital that is medically, aesthetically, and environmentally state-of-the-art. The multi-year undertaking incorporates long-term growth and revitalization strategies for all major components embraced by the new NYU Langone Medical Center — NYU School of Medicine, Tisch Hospital, Rusk Institute of Rehabilitation Medicine, NYU Hospital for Joint Diseases, NYU Cancer Institute, NYU Child Study Center, Smilow Research Center, Skirball Institute of Biomolecular Medicine, and Hassenfeld Children’s Center for Cancer and Blood Disorders — as well as campus-wide infrastructure and all off-site facilities.
In addition to his involvement with the Medical Center, Mr. Langone is also vice chairman of the Board of Overseers of the Leonard N. Stern School of Business, where the evening program in which he earned his M.B.A. is now named in his honor. In 2004, New York University presented Mr. Langone with its highest honor, The Albert Gallatin Medal, in recognition of his business acumen, his unwavering commitment to the institution, and his philanthropic legacy.
Mr. Langone also guides some of the nation’s premier medical, cultural, and charitable institutions as a director and a trustee, including the Damon Runyon Cancer Research Foundation, the Ronald McDonald House, and the Robin Hood Foundation.
Mrs. Langone, a philanthropist in her own right, is extremely active in the nonprofit community. She serves on the boards of the Boys’ Club of New York, the Animal Medical Center, and Raymond Kravis Center for the Performing Arts (West Palm Beach, FL). She formerly served on the boards of Family Services, Franciscan Sisters of the Poor Foundation, and the Children’s Advocacy Center of Manhattan. Mr. and Mrs. Langone are avid golfers and have traveled extensively throughout the world.
Langone Gift Attracts Others: Another $50 Million
The two gifts recently inspired by the Langones include a transformative $45 million being donated by philanthropists Fiona Druckenmiller and her husband, Stanley. Mrs. Druckenmiller, a former portfolio manager for the Dreyfuss Corp., has been a Trustee since 2006. The Druckenmillers’ gift, like that of the Langones, is almost entirely unrestricted and will also help support the vision articulated by the new leadership team focused on growth and advancement.
Marjorie and Walter Buckley, Jr., of Bethlehem, PA, have been friends and business associates of the Langones for 35 years. The Buckleys were original investors in Home Depot, the company that Mr. Langone co-founded and built; Mrs. Buckley conceived the name of the fledgling business. Their gift of $5 million will create a scholarship fund in Mr. Langone’s honor.
Located in the heart of New York City, NYU Langone Medical Center is one of the nation’s premier centers of excellence in health care, biomedical research, and medical education. For over 167 years, NYU physicians and researchers have made countless contributions to the practice and science of health care. Today the Medical Center consists of NYU School of Medicine, including the Smilow Research Center, the Skirball Institute of Biomolecular Medicine, and the Sackler Institute of Graduate Biomedical Sciences; the three hospitals of NYU Hospitals Center, Tisch Hospital, a 726-bed acute-care general hospital, Rusk Institute of Rehabilitation Medicine, the first and largest facility of its kind, and NYU Hospital for Joint Diseases, a leader in musculoskeletal care; and such major programs as the NYU Cancer Institute, the NYU Child Study Center, and the Hassenfeld Children’s Center for Cancer and Blood Disorders. The Langone renaming will not mean a change in any existing, individually-named facilities at the Medical Center.
As an integral part of an academic medical center, NYU’s clinical services are continually informed and enhanced by hundreds of ongoing basic and clinical research projects, as well as by major initiatives in translational research that promise to speed the transfer of laboratory discoveries to the patient’s bedside. Additionally, the strengths of NYU Langone Medical Center include the talents of affiliates and partners, such as Bellevue Hospital Center and the Manhattan Veterans Affairs Medical Center.